secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2023-01-27T23:59:59+00:00
Accession:  0001104659-23-007513
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PacBio prices 17.5M-share offering at $10/shr; expected net proceeds ~$189.2M
-----------------------------------------------------------------------------

- Sold 17.5M shares plus full exercise of underwriter option for 2.625M additional shares at $10.00 per share.
- Gross proceeds ~$175M before option; net proceeds after discounts/expenses expected ~$189.2M.
- Net proceeds to fund R&D, commercial infrastructure, working capital, and potential acquisitions.
- Underwriters include Goldman Sachs, Morgan Stanley, Cowen, and Allen & Company; offering closed January 27, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000110465923007513/0001104659-23-007513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000110465923007513/tm234462d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-007513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer